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Abstract: Xenoantigens cause hyperacute rejection and limit the success of interspecific xenografts.
Therefore, genes involved in xenoantigen biosynthesis, such as GGTA1, CMAH, and B4GALNT2,
are key targets to improve the outcomes of xenotransplantation. In this study, we introduced
a CRISPR/Cas9 system simultaneously targeting GGTA1, CMAH, and B4GALNT2 into in vitro-
fertilized zygotes using electroporation for the one-step generation of multiple gene-edited pigs
without xenoantigens. First, we optimized the combination of guide RNAs (gRNAs) targeting GGTA1
and CMAH with respect to gene editing efficiency in zygotes, and transferred electroporated embryos
with the optimized gRNAs and Cas9 into recipient gilts. Next, we optimized the Cas9 protein concen-
tration with respect to the gene editing efficiency when GGTA1, CMAH, and B4GALNT2 were targeted
simultaneously, and generated gene-edited pigs using the optimized conditions. We achieved the one-
step generation of GGTA1/CMAH double-edited pigs and GGTA1/CMAH/B4GALNT2 triple-edited
pigs. Immunohistological analyses demonstrated the downregulation of xenoantigens; however,
these multiple gene-edited pigs were genetic mosaics that failed to knock out some xenoantigens.
Although mosaicism should be resolved, the electroporation technique could become a primary
method for the one-step generation of multiple gene modifications in pigs aimed at improving
pig-to-human xenotransplantation.
Keywords: CRISPR/Cas9; GGTA1; CMAH; B4GALNT2; pig; in vitro fertilization; electroporation
1. Introduction
Demand for organ transplantation has increased substantially as a result of the con-
temporary prolongation of life expectancy and corresponding increases in the incidence of
chronic diseases and end-stage organ failure [1,2]. Xenotransplantation is one solution to
overcome the shortage of organs for human transplantation. Pig organs are ideal for this
purpose owing to their close similarity to human organs, especially in terms of size and
structure. However, multiple hurdles, including immunological barriers, need to be over-
come for their utilization as an alternative tissue source. In particular, xenoantigens limit
the success of interspecific xenografts. Antibody–xenoantigen complexes lead to comple-
ment activation and immediate hyperacute rejection [3]. The galactosyl-alpha 1,3-galactose
(Galα(1,3)Gal) epitope [4], glycans modified with N-glycolylneuraminic acid (Neu5Gc) [5],
and Sda [6] are the major carbohydrate xenoantigens expressed in porcine tissues causing
hyperacute rejection. Galα(1,3)Gal is not expressed in humans but is expressed on the sur-
face of porcine endothelial cells [2,4]. The biosynthesis of Galα(1,3)Gal is regulated by α1,3-
galactosyltransferase, encoded by glycoprotein galactosyltransferase alpha 1,3 (GGTA1) [4].
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Inactivation of Galα(1,3)Gal is the first step in successful xenotransplantation. Further-
more, Neu5Gc synthesized by cytidine monophospho-N-acetylneuraminic acid hydrox-
ylase (CMAH) [5,7] and Sda synthesized by beta-1,4-N-acetyl-galactosaminyltransferase
2 (B4GALNT2) [6] need to be eliminated to reduce pig organ rejection and prolong sur-
vival. Humans, but not non-human primates, make an array of antibodies to Neu5Gc-
modified glycans [8,9]. Sda has been examined as a non-Gal porcine xenogeneic antigen
and B4GALNT2 is expressed in major vascularized organs [6]. Humans typically produce
low levels of antibodies against Sda [10].
Genetically modified pigs without these xenoantigens will dramatically improve the
success of pig-to-human xenotransplantation. GGTA1, CMAH, and B4GALNT2 triple-
knockout pigs generated using somatic cell nuclear transfer (SCNT) significantly reduced
human IgG and IgM antibody binding to porcine peripheral blood monocytes, red blood
cells [11–13], and the pericardium [14]. However, SCNT requires sophisticated techniques,
including micromanipulator systems for the nuclear transfer of donor cells [15]. In mice,
electroporation is widely used to introduce the CRISPR/Cas9 system, consisting of Cas9
and a guide RNA (gRNA), into zygotes, resulting in efficient gene editing [16]. We es-
tablished the GEEP (“gene editing by electroporation of Cas9 protein”) method [17] for
electroporation-mediated gene editing using the CRISPR/Cas9 system in porcine zygotes
without complicated micromanipulation techniques. We previously generated pig models
of disease [18,19], as well as GGTA1-deficient pigs using GEEP [20]. However, as de-
scribed above, all major xenoantigens expressed in porcine tissues should be removed for
successful xenotransplantation.
Establishing multiple gene-knockout pig lines by mating pigs carrying a mutation
in a single gene is time-consuming and costly. Therefore, the one-step generation of
multiple gene-disrupted pigs will dramatically accelerate subsequent phenotypic analyses
and provide a more realistic approach for improving outcomes in xenotransplantation.
Although we have previously demonstrated multiple gene editing using GEEP [21,22],
the generation of multiple gene-edited offspring from electroporated zygotes has not
yet been attempted. In this study, we generated multiple gene-edited pigs from zygotes
electroporated with gRNAs targeting two genes (GGTA1 and CMAH) and three genes
(GGTA1, CMAH, and B4GALNT). Our results support the use of GEEP for the one-step
establishment of genetically modified pigs, which may serve as a resource for pig-to-human
xenotransplantation studies.
2. Results
2.1. Generation of GGTA1/CMAH Double-Edited Pigs
We previously optimized an efficient gRNA targeting GGTA1 (GGTA1#5) (Table S1)
and successfully generated GGTA1 biallelic mutant pigs using this gRNA [20]. For CMAH
gene editing, two efficient gRNAs (CMAH#1 and #2) have been confirmed using in vitro-
fertilized zygotes [21]. We designed an additional gRNA targeting CMAH (CMAH#3)
(Table S1) and evaluated the effects of combinations of gRNAs on embryonic development
and gene editing efficiency. GGTA1#5 and CMAH#1, #2, or #3 were each added at a
concentration of 100 ng/µL and introduced into in vitro-fertilized zygotes using electro-
poration (five 1 ms square pulses at 25 V), along with 100 ng/µL Cas9. We analyzed the
blastocyst formation rate from electroporated embryos. Additionally, the genotypes of
blastocysts were determined using Sanger sequencing. The TIDE (tracking of indels by
decomposition) bioinformatics package [23] was used to determine the genome editing
efficiency of each gRNA combination (Figure 1). In this study, blastocysts carrying more
than one type of mutation and the wild-type (WT) sequence were defined as mosaics. The
blastocyst formation rate did not differ significantly among zygotes treated with different
gRNA combinations (Figure 1a). However, the rate of blastocysts carrying mutations in
both GGTA1 and CMAH was significantly higher (p < 0.05) for zygotes with GGTA1#5 and
CMAH#3 than for zygotes with GGTA1#5 and CMAH#2 (Figure 1b). When we evaluated
mutations introduced into each targeting gene, the rate of blastocysts carrying biallelic
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mutations in the CMAH gene was also higher for zygotes with CMAH#3 than for zygotes
with CMAH#1 or CMAH#2 (Figure S1). Therefore, we used GGTA1#5 and CMAH#3 to
generate GGTA1/CMAH double-edited pigs.
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Cas9 and two gRNAs (GGTA1#5 and CMAH#3) were introduced into zygotes using
electroporation. These zygotes were then transferred into the oviducts of three recipient
gilts (approximately 200 zygotes/gilts). One recipient gilt became pregnant and gave birth
to three piglets. A deep sequencing analysis of D A sa ples derived fro ear biopsy
sa ples of the delivered piglets was performed to evaluate the gene editing efficiency. Two
of the three piglets (#2 and #3) carried mutations in both GGTA1 and CMAH (Figure 2).
Piglets #1 and #2 had no WT sequences in the GGTA1 genomic regions flanking the target
sites; therefore, they were considered GGTA1 biallelic mutants. However, we could not
obtain CMAH biallelic mutant pigs. The expression levels of th Galα(1,3)Gal and Neu5Gc
epitopes were assess d by taining with Alexa 488-labeled isolectin B4 and an anti-Neu5Gc
tibody, respectively, in ear biopsy tissues derived from GGTA1 and CMAH double-edite
pigs (#2 and #3). The histological analysis ndicated a GGTA1 defici ncy in piglet #2
(Figure 3a). The expression of Galα(1,3)Gal in piglet #3 carryi g a mosaic mutation in
GGTA1 was similar to that in the WT. The expression of the Neu5Gc epitope in pigl ts #2
and #3 carry ng a mosaic mut tion in CMAH was also similar to that in the WT (Figure 3b).
2.2. Generation of GGTA1/CMAH/B4GALNT Triple-Edited Pigs
We previously validated a highly efficient gRNA targeting B4GALNT2 [24], referred to
as B4GALNT2#1 (Table S1). To improve the gene editing efficiency by targeting three genes,
we evaluated the effects of the Cas9 concentration on gene editing via the GEEP method.
GGTA1#5, CMAH#3, and B4GALNT2#1 were mixed at a concentration of 100 ng/µL and
introduced into the in vitro-fertilized zygotes using electroporation along with 100 ng/µL,
200 ng/µL, or 400 ng/µL of Cas9. The gene editing efficiency was affected by the Cas9
concentration. The rates of blastocysts carrying mutations in all targeted genes were
significantly higher (p < 0.05) in embryos electroporated with 200 and 400 ng/µL Cas9
than in embryos electroporated with 100 ng/µL Cas9 (Figure 4b). When we evaluated
mutations introduced into each targeting gene, the rate of blastocysts carrying biallelic
mutations and the gene editing efficiency in the mutant blastocysts also increased as the
Cas9 concentration increased in CMAH and B4GALNT2 genes (Figure S2). However, the
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blastocyst formation rate of embryos electroporated with 400 ng/µL Cas9 was significantly
lower (p < 0.05) than that of embryos electroporated with 100 ng/µL Cas9 (Figure 4a),
indicating that the electroporation of 400 ng/µL Cas9 was harmful to subsequent embryonic
development. Therefore, a Cas9 concentration of 200 ng/µL was optimal to generate
GGTA1/CMAH/B4GALNT2 triple-edited pigs in this study.
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Next, we evaluated the expression levels of Galα(1,3)Gal, Neu5Gc, and Sda epitopes
(Figure 6). In piglet #4, levels of Galα(1,3)Gal and Sda epitopes were lower than those in
WT controls, and the expression of the Neu5Gc epitope was observed. In piglet #5, the
downregulation of Galα(1,3)Gal and Neu5Gc epitopes indicated a deficiency in GGTA1
Int. J. Mol. Sci. 2021, 22, 2249 6 of 14
and CMAH (Figure 6a,b). The expression of the Sda epitope in piglet #5 carrying an inframe
mutation was similar to that in the WT (Figure 6c).
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gRNA combinations on embryonic viability and the gene editing efficiency using in vitro 
Figure 6. Immunohistochemical assessment of wild-type, GGTA1/B4GALNT2 double-edited (#4), and GGTA1/CMAH/
B4GALNT2 triple-edited (#5) piglets. The ear biopsies derived from wild-type (WT) and mutant piglets (#4 and #5) were
immunohistochemically stained for Galα(1,3)Gal (green) (a), Neu5Gc (green) (b), and Sda (red) (c). These tissues were
counterstained with 4′, 6-diamidino-2-phenylindole (DAPI) (blue). The scale bar in each panel represents 50 µm.
3. Discussion
In this study, based on the CRISPR/Cas9 system, we successfully generated GGTA1/CMAH
double-edited and GGTA1/CMAH/B4GALNT2 triple-edited pigs using the GEEP method.
Multiple gene-edited animals have been generated using the cytoplasmic microinjection of
CRISPR/Cas9 in mice [25,26], rats [27], and monkeys [28]. In pigs, the SCNT technique is a
primary method for generating multiple gene-modified pigs, while one-step multiple gene
editing during embryogenesis has been achieved by microinjection alone [29]. To the best
of our knowledge, this is the first demonstration of the generation of multiple gene-edited
pigs from CRISPR/Cas9-mediated gene-edited zygotes using electroporation, which is a
simple and micromanipulation-free method.
First, we generated GGTA1/CMAH double-edited pigs after evaluating the effects of
gRNA combinations on embryonic viability and the gene editing efficiency using in vitro
cultured blastocysts. Cross-talk between gRNAs, in which a gRNA affects the gene editing
efficiency of another gRNA, is a concern. In our previous study, when porcine zygotes
were electroporated with pooled gRNAs targeting multiple genes, the mutation rates in
each gene were lower than those after electroporation with single gRNAs [21]. In this
study, we used gRNAs (GGTA1#5, CMAH#1 and #2) that induce gene editing in zygotes
with high efficiency when used individually. However, this study demonstrated that
the simultaneous introduction of gRNAs targeting GGTA1 and CMAH reduces the rate of
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blastocysts carrying biallelic mutations compared with the single-use results of our previous
study [20,21]. CMAH#3, which is a newly designed gRNA introduced in this study,
showed a higher biallelic mutation rate compared with CMAH#1 and #2 (Figure S1). When
low gene-editing results, presumably due to cross-talk between gRNAs, were observed
during multiple gene targeting, a redesign of the gRNA can be one of the approaches
used to improve efficiency. On the other hand, the combination of gRNAs targeting
GGTA1 and CMAH did not affect the developmental competence of electroporated zygotes.
Therefore, we selected a gRNA combination that maximized the gene editing efficiency.
After the transfer of electroporated zygotes with gRNAs, two of three piglets carried
mutations in the GGTA1 and CMAH genes; however, mosaicism prevented the inactivation
of the Neu5Gc epitope. An immunohistochemical analysis revealed the expression of
Neu5Gc in both GGTA1/CMAH double-edited pigs. Therefore, to further optimize the
conditions for gene editing, we evaluated various Cas9 concentrations for the generation
of GGTA1/CMAH/B4GALNT2 triple-edited pigs using GEEP in Experiment 2.
The interference of gene editing, presumably due to cross-talk between gRNAs,
was also observed in Experiment 2. The simultaneous introduction of gRNA targeting
B4GALNT2 induced a lower biallelic mutation rate compared with our previous study in
which gRNAs were used individually [24]. gRNA targeting CMAH also demonstrated
fewer gene-editing events when used to induce triple gene editing compared with when it
was used to induce double editing in Experiment 1. Both were introduced into zygotes
with 100 ng/µl Cas9 (Figure S2). Elevation of the Cas9 concentration improves the rate
of blastocysts carrying biallelic mutations and the gene editing efficiency in the mutant
blastocysts. We confirmed that electroporation with 200 ng/µL Cas9 induced mutations in
three targeted genes with high efficiency and minimal effects on embryonic development.
In this study, although the amount of gRNA was kept constant, gene editing efficiency
was improved via the addition of more Cas9 protein. This result indicates that gRNAs are
enough for our electroporation-mediated introduction. Thus, adding more Cas9 resulted
in an increase in the amount of active CRISPR/Cas9 ribonucleoprotein. In our previous
study, we investigated the effect of various concentrations of Cas9 (0 to 1000 ng/µL) on
the development and gene editing of porcine embryos via electroporation using a single
gRNA targeting the myostatin gene [30]. The biallelic mutation rate and editing efficiency
increased as the Cas9 protein concentration increased. However, the development of blas-
tocysts from electroporated zygotes was not affected by the Cas9 concentration, in contrast
with the results of this study. One explanation for the decrease in blastocyst formation rates
in our study is that multiple gene editing may affect embryo viability. In our previous study,
targeting four genes simultaneously did not negatively affect blastocyst formation [21],
presumably because the mutation rate in each gene was lower than that for electropora-
tion with single gRNAs. In mice, quintuple gene modification has been achieved by the
microinjection of the CRISPR/Cas9 system into one-cell stage embryos [26]; in this study,
the number of pups decreased as the gene editing efficiency increased. On the other hand,
triple-mutated rats have been generated by the co-microinjection of three gRNAs targeting
different genes without affecting embryonic viability [27]. The combination of gRNAs,
concentrations of gRNAs and Cas9 protein/mRNA, targeting genes, and animal species
are possible factors affecting the viability of zygotes and embryos following gene editing.
After the embryo transfer of zygotes with three gRNAs along with Cas9, we generated
GGTA1/CMAH/B4GALNT2 triple-edited pigs under optimized conditions. However,
the triple-edited pigs also carried a mosaic mutation. Avoiding mosaicism is crucial
with respect to time, labor, and costs, especially in pigs, as large experimental animals,
because mosaicism in the founder generation requires subsequent breeding for stable
phenotype expression. Gene editing of zygotes/embryos using the CRISPR/Cas9 system
poses a risk of mosaicism [17,31]. In one study using rats, the CRISPR/Cas9 system
introduced into in vitro-fertilized embryos using electroporation disrupted genes with
100% efficiency [32]. In the case of marmoset embryos manipulated by the cytoplasmic
microinjection of gene editors, optimized conditions using transcription activator-like
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effector nucleases (TALENs) achieved highly efficient gene disruption with low or no
mosaicism [33], whereas higher mosaicism was observed when the CRISPR/Cas9 system
was used [34]. Further optimization of gene editing using gene editors is required in pigs.
In this study, in order to reduce mosaicism, we optimized the Cas9 concentration.
However, this approach may affect off-target events. Off-target effects, such as unexpected
DNA cleavage caused by the binding of gene editors to unintended genomic sites, is a
major concern in gene editing. Ryczek et al. confirmed off-target mutations induced by
CRISPR/Cas9 system after targeting xenotransplantation-related genes including GGTA1,
CMAH, and B4GALNT2 [35]. In this study, we designed gRNAs using the COSMID webtool
to minimize off-target effects; however, further strategies are crucial, especially for clinical
applications in humans requiring precise gene modification.
To minimize the off-target effects and improve practical gene editing, the latest ap-
proaches were developed, e.g., off-target detection by algorithmically-designed software
and genome-wide assays, cytosine or adenine base editors, prime editing, Cas9 variants
including dCas9 and Cas9 paired nickase, and the chemical modification of gRNA [36].
A high-fidelity Cas9 mutant also resulted in high on-target activity while reducing off-
target effects in human cells [37]. Furthermore, well-designed gRNA with high specificity
using tools to detect and evaluate the gRNA efficiency will reduce the labor required to
analyze off-target candidates [36,38]. gRNAs should be carefully designed to minimize
the likelihood of off-target effects; however, the potential for off-target events cannot be
completely eliminated. In our previous study, although the increasing concentration of
CRISPR/Cas9 components was effective in increasing gene editing efficiency without
off-target events [30], the frequency of mosaicism has the potential to vary with the organs
derived from founder pigs [20]. We should minimize off-target events by utilizing the
latest developed strategies in founder generations, and evaluate possible off-target events
of non-mosaic genetically-modified donor lines for xenotransplantation prior to a clinical
application for humans.
GGTA1/CMAH/B4GALNT2-deficient pigs are a promising resource for pig-to-human
xenotransplantation. Furthermore, the expression of human complement regulators in pigs
is one approach to control complement activation, which induces hyperacute rejection [2,39].
As a next step, multiple gene modifications, including knock-ins of human genes, will
be essential to prolong the function of xenotransplanted pig organs in humans. Using
electroporation with the CRISPR/Cas9 system, the knock-in of long single-stranded DNAs
(600 to 1500 bases) has been successfully demonstrated in mice [40]. However, in pigs,
the size of molecules introduced into zygotes or embryos is limited because porcine
in vitro-fertilized zygotes have greater sensitivity to electricity than that of in vivo-derived
mouse embryos [17,41]. A high electroporation voltage to introduce large molecules has
harmful effects on embryonic viability [41]. To deliver the knock-in donor DNA into
zygotes, an adeno-associated viral (AAV) vector has been applied in mice [42] and rats [32]
without removing the zona pellucida, requiring no sophisticated techniques. In pigs, the
development of new, efficient delivery techniques of large molecules for zygotes and
embryos is crucial.
In conclusion, the GEEP method can be used to generate multiple gene-modified
pigs. Although mosaicism should be resolved, this simple technique could become a
primary method for the one-step generation of multiple gene modifications using the
CRISPR/Cas9 system.
4. Materials and Methods
4.1. Animals
The animal experiments were approved by the Institutional Animal Care and Use
Committee of Tokushima University (approval number: T2019-11, date of approval: 9
April 2019). All animal care and experimental procedures, including the determination of
experimental endpoints, were performed in accordance with the Guidelines for Animal
Experiments of Tokushima University. All animals were housed and maintained in accor-
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dance with Institutional Animal Care and Use Committee guidelines. Four sexually mature
Landrace gilts were obtained from the Tokushima Prefectural Livestock Research Institute
(Tokushima, Japan). Pigs were housed in a temperature-controlled room (25 ± 3 ◦C) under
a 12 h light/12 h dark cycle with free access to water and were provided with commercial
feed (JA Nishinihon Kumiai Shiryou, Hyogo, Japan). The health condition of each pig
was observed daily by the animal husbandry staff under the supervision of an attending
veterinarian. To minimize animal suffering, all surgical procedures were performed under
anesthesia by intramuscular injection of 10 mg/kg ketamine (Ketalar, ketamine hydrochlo-
ride, Daiichi Sankyo Pharmaceutical, Tokyo, Japan) and continuous inhalation of 2% to
3% isoflurane (Mylan, Osaka, Japan) in the operating room. Euthanasia was performed by
intravenous injection of a potassium chloride solution (3 mmol/kg) under deep anesthesia
by isoflurane according to the American Veterinary Medical Association Guidelines for the
Euthanasia of Animals.
4.2. Oocyte Collection, In Vitro Maturation, and Fertilization
Pig ovaries were obtained from prepubertal gilts (Landrace × Large White × Duroc
breeds) at a local slaughterhouse and were transported in physiological saline within 1 h to
the laboratory at 30 ◦C. Ovaries were washed three times with prewarmed physiological
saline solution supplemented with 100 IU/mL penicillin G potassium (Meiji, Tokyo, Japan)
and 0.1 mg/mL streptomycin sulfate (Meiji). Follicles with diameters of 3–6 mm on the
ovarian surface were placed on a sterilized dish using a surgical blade, and cumulus–oocyte
complexes (COCs) were visualized and collected under a stereomicroscope. Approximately
50 COCs were cultured in 500 µL of maturation medium consisting of tissue culture
medium 199 with Earle’s salts (TCM 199; Gibco/Invitrogen Co., Carlsbad, CA, USA)
supplemented with 10% (v/v) porcine follicular fluid, 0.6 mM cysteine (Sigma-Aldrich,
St. Louis, MO, USA), 50 µM β-mercaptoethanol (Wako Pure Chemical Industries Ltd.,
Osaka, Japan), 50 µM sodium pyruvate (Sigma-Aldrich), 2 mg/mL D-sorbitol (Wako Pure
Chemical Industries Ltd.), 10 IU/mL equine chorionic gonadotropin (eCG; Kyoritu Seiyaku,
Tokyo, Japan), 10 IU/mL human chorionic gonadotropin (hCG; Kyoritu Seiyaku), and
50 µg/mL gentamicin (Sigma-Aldrich), then covered with mineral oil (Sigma-Aldrich) for
22 h in 4-well dishes (Nunc A/S, Roskilde, Denmark). The COCs were transferred into
maturation medium without hormones for an additional 22 h. COCs were incubated at
39 ◦C in a humidified incubator containing 5% CO2.
The matured oocytes were subjected to in vitro fertilization as described previously [43].
Briefly, frozen–thawed ejaculated spermatozoa collected from WT boar were transferred
into 5 mL of porcine fertilization medium (PFM; Research Institute for the Functional
Peptides Co., Yamagata, Japan) and washed using centrifugation at 500× g for 5 min.
The pelleted spermatozoa were resuspended in fertilization medium and adjusted to a
density of 1 × 106 cells/mL. Approximately 50 oocytes were transferred to 500 µL of
sperm-containing fertilization medium, covered with mineral oil in 4-well dishes, and
co-incubated for 5 h at 39 ◦C in a humidified incubator containing 5% CO2, 5% O2, and
90% N2. After co-incubation, the putative zygotes were denuded from the cumulus cells
and attached spermatozoa by mechanical pipetting, transferred to porcine zygote medium
(PZM-5; Research Institute for the Functional Peptides Co.), and cultured for 7 h until
electroporation.
4.3. Electroporation
Electroporation was performed as described previously [17]. Briefly, an electrode
(LF501PT1-20; BEX, Tokyo, Japan) was connected to a CUY21EDIT II electroporator (BEX)
and was set under a stereoscopic microscope. The 50 inseminated zygotes were washed
with Opti-MEM I solution (Gibco/Invitrogen, Carlsbad, CA, USA) and placed in a line
in the electrode gap in a chamber slide filled with 10 µL of nuclease-free duplex buffer
(IDT; Integrated DNA Technologies, Coralville, IA, USA) containing gRNA (Alt-R CRISPR
crRNAs and tracrRNA, chemically modified and length-optimized variants of the native
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guide RNAs purchased from IDT), and Cas9 protein (Guide-it Recombinant Cas9; Takara
Bio, Shiga, Japan). According to the manufacturer’s instructions, crRNA contains chemical
modifications to protect it from degradation by cellular RNases, and tracrRNA contains
chemical modifications conferring high nuclease resistance. gRNAs were designed using
the CRISPRdirect webtool (https://crispr.dbcls.jp/ accesed date: 25 January 2021) [44]. To
minimize off-target effects, the 12 bases at the 3’ end of the designed gRNAs had no identical
sequence matches to the pig genome other than the target regions of GGTA1, CMAH, and
B4GALNT2, as determined using the COSMID webtool (https://crispr.bme.gatech.edu/
accesed date: 25 January 2021), which scores and ranks off-target candidate sequences
based on locations and numbers of base mismatches, deletions, and insertions, when
compared to the gRNA sequence [45].
After electroporation (five 1 ms square pulses at 25 V), the zygotes were washed
with PZM-5 and cultured until embryo transfer (for 12 h) or for 3 days. The embryos
that were cultured for 3 days were subsequently incubated in porcine blastocyst medium
(PBM; Research Institute for the Functional Peptides Co.) for 4 days to evaluate their
ability to develop to the blastocyst stage and for blastocyst genotyping. As a control,
some of the inseminated zygotes were cultured with PZM-5 and PBM for 7 days without
electroporation. Zygotes and embryos were incubated at 39 ◦C in a humidified incubator
containing 5% CO2, 5% O2, and 90% N2.
4.4. Analysis of the Targeted Gene after Electroporation
Genomic DNA was isolated from blastocysts by boiling in a 50 mM NaOH solution.
After neutralization, the genomic regions flanking the gRNA target sequences were PCR-
amplified using specific primers (Table S1). PCR products were extracted by agarose
gel electrophoresis. The targeted genomic regions were directly sequenced using Sanger
sequencing with the BigDye Terminator Cycle Sequencing Kit ver. 3.1 (Thermo Fisher
Scientific, Waltham, MA, USA) and the ABI 3500 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA). The TIDE bioinformatics package [23] was used to determine the
genotypes of blastocysts, which were classified as having biallelic mutations (carrying no
WT sequences), mosaics (carrying more than one type of mutation and the WT sequence), or
WT (carrying only the WT sequence). Gene editing efficiency was defined as the proportion
of indel mutation events in the blastocyst that carried the mosaic or biallelic edit.
4.5. Embryo Transfer
Recipient gilts, after estrous cycles were synchronized, were prepared for embryo
transfer as described previously [46]. In brief, 0.2 mg of cloprostenol (Planate; MSD Animal
Health, Tokyo, Japan) was administered by intramuscular (i.m.) injection to pregnant gilts
35 to 53 days after the day of insemination. Subsequently, a second intramuscular injection
of 0.2 mg of cloprostenol and intramuscular injection of 1000 IU of eCG (PMSA for Animal,
ZENOAQ, Fukushima, Japan) was administered to the gilts 24 h after the first injection of
cloprostenol. At 72 h after the intramuscular injection of eCG, 1500 IU of hCG (Gestron
1500, Kyoritsu Seiyaku, Tokyo, Japan) was administered to the gilts. Approximately 72 h
after the hCG i.m. injection, one- to two-cell stage embryos that were electroporated
approximately 12 h before embryo transfer were transferred into the oviducts of a recipient
gilt under anesthesia. The gilts were placed in the supine position, and the surgical area
was disinfected with povidone–iodine (Meiji Seika Pharma, Tokyo, Japan). Approximately
100 zygotes were transferred to each oviduct, resulting in the transfer of 200 zygotes per
gilt under sterile conditions.
4.6. Mutation Analysis of Piglets Using Deep Sequencing
Ear biopsies were collected from piglets under anesthesia by continuous inhalation
of 2–3% isoflurane. Genomic DNA was isolated from the ear biopsies by boiling in a
50 mM NaOH solution. After neutralization, the genomic regions flanking the gRNA target
sequences were amplified by two-step PCR using specific primers (Table S2) and the index
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PCR primers following the manufacturer’s instructions (Illumina, Hayward, CA, USA).
After gel purification, the amplicons were subjected to MiSeq sequencing using the MiSeq
Reagent Kit v. 2 (250 cycles) (Illumina, San Diego, CA, USA). The mutation rates were
defined as the ratio of the number of mutant amplicons to the total read count. A small
number of amplicons carrying different sequences that were also detected in WT samples
were excluded as sequencing errors. Piglets that carried no WT sequences were classified
as having biallelic mutations. Those carrying more than one type of mutation and the
WT sequence were classified as mosaics. Piglets that carried only the WT sequence were
classified as the WT.
4.7. Immunohistochemical Assessment of Piglets
Ear biopsies were collected from pigs, fixed in a 4% paraformaldehyde neutral-
buffered solution (Wako, Osaka, Japan), and manually embedded in paraffin. Paraffin-
embedded sections were deparaffinized in xylene and rehydrated in decreasing concen-
trations of ethanol. Blocking treatment was performed by incubation with 10% normal
goat serum in phosphate-buffered saline (PBS) for 2 h at 25 ◦C. To detect the Galα(1,3)Gal
epitope, the sections were incubated overnight with 10 µg/mL isolectin B4-Alexa 488
(Thermo Fisher Scientific) at 4 ◦C. For the detection of Neu5Gc, the sections were incubated
overnight with the primary antibody (chicken anti-Neu5Gc polyclonal antibody; clone
Poly21469, 146903, 1:100 dilution; BioLegend, San Diego, CA, USA) at 4 ◦C and were
subsequently incubated for 2 h at room temperature with an Alexa Fluor 488-conjugated
goat anti-chicken secondary antibody (A-11039, 4 µg/mL; Thermo Fisher Scientific). For
the detection of Sda, 20 µg/mL Dolichos biflorus agglutinin labeled with rhodamin (RL-1032;
Vector Laboratories, Burlingame, VT, USA) was used. Nuclei were counterstained with
4′, 6-diamidino-2-phenylindole (DAPI). The tissues were examined using fluorescence
microscopy (BZ-X710; Keyence, Osaka, Japan).
4.8. Statistical Analyses
Percentage data for embryos that developed to the blastocyst stage were subjected to
arcsine transformation before analysis of variance (ANOVA). The transformed data were
evaluated using ANOVA, followed by the protected Fisher’s least significant difference
test. The analysis was performed using StatView (Abacus Concepts, Berkeley, CA, USA).
The percentage of mutated blastocysts was analyzed using the chi-squared test. Differences
with a p-value of ≤0.05 were considered statistically significant.
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ANOVA analysis of variance
B4GALNT2 beta-1,4-N-acetyl-galactosaminyltransferase 2
Cas9 CRISPR-associated system 9
CMAH cytidine monophospho-n-acetylneuraminic acid hydroxylase
CRISPR clustered regularly interspaced short palindromic repeat
eCG equine chorionic gonadotropin
GEEP gene editing by electroporation of cas9 protein
GGTA1 glycoprotein galactosyl transferase alpha 1,3
hCG human chorionic gonadotropin
PAM protospacer adjacent motif
PCR polymerase chain reaction
TIDE tracking of indels by decomposition
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